COVID-19 computing consortium focusing on near-term COVID-19 therapies

By The Science Advisory Board staff writers

November 17, 2020 -- The COVID-19 High Performance Computing (HPC) Consortium said that it has entered a new phase of operation focused on helping researchers identify potential near-term therapies for COVID-19 patients.

With a greater volume of COVID-19 data now available, the public-private consortium said it has decided to focus on research projects that hold potential to help improve patient outcomes within a six-month timeframe.

The 43-member consortium was created in May by IBM, the White House Office of Science and Technology Policy, and the U.S. Department of Energy to bring together computing resources, software, and services to help researchers around the world understand COVID-19, its treatments, and potential cures.

In its new operational phase, the consortium said it's particularly interested in projects focused on:

  • Understanding and modeling patient response to the virus using large clinical datasets
  • Learning and validating vaccine response models from multiple clinical trials
  • Evaluating combination therapies using repurposed molecules
  • Epidemiological models driven by large multimodal datasets
U.S. government expands assistance to J&J COVID-19 vaccine research
The Biomedical Advanced Research and Development Authority is expanding its partnership with Johnson & Johnson by providing additional support for...
Interactive virtual reality system helps drug designers fight COVID-19
A new virtual reality tool offers scientists a chance to "step inside" the SARS-CoV-2 virus's main enzyme responsible for replication and manipulate it...
Accelerating COVID-19 drug repurposing with computers, organ chips
The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded the Wyss Institute for Biologically Inspired Engineering at Harvard University...
COVID-19 research consortium expands
The EndPandemic National Data Consortium is about to expand by six life sciences and information technology companies.

Copyright © 2020 scienceboard.net


Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter